Product Information
CLOMIPRAMINE 50 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2581 per EA under NDC 59651038230. Its NADAC has been published 166 times since Aug 2, 2023.
FDA first approved this application on Mar 20, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651038230
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CLOMIPRAMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216440FDA Approved
3/20/2023
TE Code
AB
On Market Since
3/20/2023
Pharmacological Classes
Price Statistics
The NADAC for CLOMIPRAMINE 50 MG CAPSULE has been published 166 times since Aug 2, 2023, and over the history we have for it it has declined 39.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2581 per EA |
|---|---|
| All-time high | $0.4242 (Jan 10, 2024) |
| All-time low | $0.2016 (May 22, 2024) |
| 52-week high | $0.2915 |
| 52-week low | $0.2257 |
| Median price | $0.2875 |
| Average price | $0.2928 |
| Largest weekly change | +43.5% (Jun 19, 2024) |
| Weeks tracked | 166 |
| Tracking since | Aug 2, 2023 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clomipramine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tricyclic Antidepressant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOMIPRAMINE 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CLOMIPRAMINE 50 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $0.2581 per EA (NDC 59651038230), effective Sep 30, 2026.
How has the price of CLOMIPRAMINE 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CLOMIPRAMINE 50 MG CAPSULE has declined 39.0%. It has been tracked across 166 weekly CMS publications since Aug 2, 2023.
What are the highest and lowest recorded NADAC prices for CLOMIPRAMINE 50 MG CAPSULE?
Since Aug 2, 2023, the NADAC for CLOMIPRAMINE 50 MG CAPSULE has ranged from a low of $0.2016 (May 22, 2024) to a high of $0.4242 (Jan 10, 2024), with a median of $0.2875 per EA.
Are there cheaper alternatives to CLOMIPRAMINE 50 MG CAPSULE?
8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLOMIPRAMINE 50 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures CLOMIPRAMINE 50 MG CAPSULE?
CLOMIPRAMINE 50 MG CAPSULE (NDC 59651038230) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.